A thermoelectric power generating heat exchanger: Part I - Experimental realization

An experimental realization of a heat exchanger with commercial thermoelectric generators (TEGs) is presented. The power producing capabilities as a function of flow rate and temperature span are characterized for two different commercial heat transfer fluids and for three different thermal interface materials. The device is shown to produce 2 W per TEG or 0.22 W cm$^{-2}$ at a fluid temperature difference of 175 $^\circ$C and a flow rate per fluid channel of 5 L min$^{-1}$. One experimentally realized design produced 200 W in total from 100 TEGs. For the design considered here, the power production is shown to depend more critically on the fluid temperature span than on the fluid flow rate. Finally, the temperature span across the TEG is shown to be 55% to 75% of the temperature span between the hot and cold fluids.Comment: 9 pages, 11 figure

Education for innovation and entrepreneurship in the food system: the Erasmus+ BoostEdu approach and results

Innovation and entrepreneurship are key factors to provide added value for food systems. Based on the findings of the Erasmus+ Strategic Partnership BoostEdu, the objective of this paper is to provide answers to three knowledge gaps: 1) identify the needs for innovation and entrepreneurship (I&E) in the food sector; 2) understand the best way to organize learning; 3) provide flexibility in turbulent times. BoostEdu aimed to provide a platform for continuing education within I&E for food professionals and was carried out through co-creation workshops and the development of an e-learning course. The results of the project in particular during the Covid-19 pandemics, highlighted the need for flexible access to modules that are complementary to other sources and based on a mix of theoretical concepts and practical experiences. The main lessons learned concern the need of co-creation and co-learning processes to identify suitable practices for the use of innovative digital technologies

Extreme Ultraviolet Variability Experiment (EVE) on the Solar Dynamics Observatory (SDO): Overview of Science Objectives, Instrument Design, Data Products, and Model Developments

The highly variable solar extreme ultraviolet (EUV) radiation is the major energy input to the Earth’s upper atmosphere, strongly impacting the geospace environment, affecting satellite operations, communications, and navigation. The Extreme ultraviolet Variability Experiment (EVE) onboard the NASA Solar Dynamics Observatory (SDO) will measure the solar EUV irradiance from 0.1 to 105 nm with unprecedented spectral resolution (0.1 nm), temporal cadence (ten seconds), and accuracy (20%). EVE includes several irradiance instruments: The Multiple EUV Grating Spectrographs (MEGS)-A is a grazing-incidence spectrograph that measures the solar EUV irradiance in the 5 to 37 nm range with 0.1-nm resolution, and the MEGS-B is a normal-incidence, dual-pass spectrograph that measures the solar EUV irradiance in the 35 to 105 nm range with 0.1-nm resolution. To provide MEGS in-flight calibration, the EUV SpectroPhotometer (ESP) measures the solar EUV irradiance in broadbands between 0.1 and 39 nm, and a MEGS-Photometer measures the Sun’s bright hydrogen emission at 121.6 nm. The EVE data products include a near real-time space-weather product (Level 0C), which provides the solar EUV irradiance in specific bands and also spectra in 0.1-nm intervals with a cadence of one minute and with a time delay of less than 15 minutes. The EVE higher-level products are Level 2 with the solar EUV irradiance at higher time cadence (0.25 seconds for photometers and ten seconds for spectrographs) and Level 3 with averages of the solar irradiance over a day and over each one-hour period. The EVE team also plans to advance existing models of solar EUV irradiance and to operationally use the EVE measurements in models of Earth’s ionosphere and thermosphere. Improved understanding of the evolution of solar flares and extending the various models to incorporate solar flare events are high priorities for the EVE team.United States. National Aeronautics and Space Administration (contract NAS5-02140

Holistic corpus-based dialectology

This paper is concerned with sketching future directions for corpus-based dialectology. We advocate a holistic approach to the study of geographically conditioned linguistic variability, and we present a suitable methodology, 'corpusbased dialectometry', in exactly this spirit. Specifically, we argue that in order to live up to the potential of the corpus-based method, practitioners need to (i) abandon their exclusive focus on individual linguistic features in favor of the study of feature aggregates, (ii) draw on computationally advanced multivariate analysis techniques (such as multidimensional scaling, cluster analysis, and principal component analysis), and (iii) aid interpretation of empirical results by marshalling state-of-the-art data visualization techniques. To exemplify this line of analysis, we present a case study which explores joint frequency variability of 57 morphosyntax features in 34 dialects all over Great Britain

Role of ionic surfactant in magnetic dynamics of self-assembled dispersions of nanoplatelets

In complex colloidal systems, interparticle interactions strongly affect the dynamics of the constituting particles. A study of the dynamical response also provides invaluable information on the character of those interactions. Here we demonstrate how tuning the electrostatic interactions by an ionic surfactant in dispersions of magnetic nanoplatelets leads to developing new dynamic modes in magnetic response spectra. The collective modes can be induced or suppressed by either varying the concentration ratio of the magnetic nanoplatelets (MP) to the surfactant or increasing the MP concentration reflecting the nanoscale characteristics of this fluid magnet. © 2023 Elsevier B.V.Deutsche Forschungsgemeinschaft, DFG: LU 800/7-1, NA 1668/1-1; Österreichischen Akademie der Wissenschaften, ÖAW; Javna Agencija za Raziskovalno Dejavnost RS, ARRS: J1-2459, P1-0192, P2-0089, PR-08415, PR-08973F.L., M.K., A.E. and H.N. acknowledge the support of the Deutsche Forschungsgemeinschaft (Projects NA 1668/1-1 and LU 800/7-1 ). D.L, N.S., P.H.-B., and A.M. acknowledge the financial support from the Slovenian Research Agency ( P1-0192 , P2-0089 , J1-2459 , PR-08973 and PR-08415 ). M.R. thanks the Austrian Academy of Sciences for funding via the DOC-Fellowship program

Effect of zoledronic acid on the doxycycline-induced decrease in tumour burden in a bone metastasis model of human breast cancer

Bone is one of the most frequent sites for metastasis in breast cancer patients often resulting in significant clinical morbidity and mortality. Bisphosphonates are currently the standard of care for breast cancer patients with bone metastasis. We have shown previously that doxycycline, a member of the tetracycline family of antibiotics, reduces total tumour burden in an experimental bone metastasis mouse model of human breast cancer. In this study, we combined doxycycline treatment together with zoledronic acid, the most potent bisphosphonate. Drug administration started 3 days before the injection of the MDA-MB-231 cells. When mice were administered zoledronic acid alone, the total tumour burden decreased by 43% compared to placebo treatment. Administration of a combination of zoledronic acid and doxycycline resulted in a 74% decrease in total tumour burden compared to untreated mice. In doxycycline- and zoledronate-treated mice bone formation was significantly enhanced as determined by increased numbers of osteoblasts, osteoid surface and volume, whereas a decrease in bone resorption was also observed. Doxycycline greatly reduced tumour burden and could also compensate for the increased bone resorption. The addition of zoledronate to the regimen further decreased tumour burden, caused an extensive decrease in bone-associated soft tissue tumour burden (93%), and sustained the bone volume, which could result in a smaller fracture risk. Treatment with zoledronic acid in combination with doxycycline may be very beneficial for breast cancer patients at risk for osteolytic bone metastasis